30 AGs Back $465M J&J Verdict In Landmark Opioid Trial
By Jeff Overley · November 30, 2020, 9:14 PM EST
A $465 million judgment against Johnson & Johnson after the first trial in a nationwide wave of opioid-crisis litigation was legally sound and strengthened other lawsuits aimed at holding pharmaceutical companies...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login